SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

SAN

76.26

-1.73%↓

UCB

250.1

-3.1%↓

SHL.DE

40.38

-0.02%↓

ARGX

620.4

-1.02%↓

PHIA

24.97

-2.19%↓

Search

Merck KGaA

Chiusa

SettoreSettore sanitario

110.05 -3.72

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

109.55

Massimo

114.3

Metriche Chiave

By Trading Economics

Entrata

250M

902M

Vendite

63M

5.3B

Rendimento da dividendi

1.34

Margine di Profitto

16.961

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+31.63% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

1.34%

2.25%

Utili prossimi

13 mag 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

98B

Apertura precedente

113.77

Chiusura precedente

110.05

Notizie sul Sentiment di mercato

By Acuity

29%

71%

72 / 351 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Merck KGaA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 mar 2026, 06:28 UTC

Utili

Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings

13 nov 2025, 13:40 UTC

Utili

Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update

13 nov 2025, 06:24 UTC

Utili

Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units

5 mar 2026, 08:40 UTC

Discorsi di Mercato

Germany's Merck KGaA Issues Weaker-Than-Expected Guidance -- Market Talk

5 mar 2026, 06:00 UTC

Utili

Merck KGaA Sees 2026 Ebitda Before Special Items at EUR5.5B-EUR6B

5 mar 2026, 06:00 UTC

Utili

Merck KGaA Sees 2026 Adj EPS EUR7.10-Adj EPS EUR8

5 mar 2026, 06:00 UTC

Utili

Analysts Saw Merck KGaA 2025 Ebitda Before Special Items EUR6.1B

5 mar 2026, 06:00 UTC

Utili

Merck KGaA Sees 2026 Sales EUR20B-EUR21B

5 mar 2026, 06:00 UTC

Utili

Merck KGaA Sees 2026 Organic Net Sales Ranging From 1% Fall to 2% Rise

5 mar 2026, 06:00 UTC

Utili

Merck KGaA 2025 Adj EPS EUR8.34

5 mar 2026, 06:00 UTC

Utili

Analysts Saw Merck KGaA 2025 Net Sales at EUR21.14B

5 mar 2026, 06:00 UTC

Utili

Merck KGaA Expects Considerable Foreign-Exchange Headwinds in 2026

5 mar 2026, 06:00 UTC

Utili

Merck KGaA Keeps Dividend at EUR2.20 a Share

5 mar 2026, 06:00 UTC

Utili

Merck KGaA 2025 After-Tax Profit EUR2.615B

5 mar 2026, 06:00 UTC

Utili

Germany's Merck KGaA Says Organic Net Sales Grew 3.1% in 2025

5 mar 2026, 06:00 UTC

Utili

Merck KGaA 2025 Sales EUR21.1B

5 mar 2026, 06:00 UTC

Utili

Merck KGaA 2025 Ebitda Before Special Items EUR6.11B

12 feb 2026, 15:20 UTC

Utili

Sanofi Shares Fall After CEO Change -- Update

20 gen 2026, 09:54 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

DAVOS: Merck KGaA Not in a Hurry for M&A, CEO Says -- Market Talk

13 nov 2025, 07:57 UTC

Discorsi di Mercato
Utili

Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Says Guidance Midpoint Remains Unchanged

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Sees 2025 Organic Sales Growth of Around 3%

13 nov 2025, 06:00 UTC

Utili

Merck KGaA 3Q After-Tax Profit EUR898M

13 nov 2025, 06:00 UTC

Utili

Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors

13 nov 2025, 06:00 UTC

Utili

Merck KGaA Narrows 2025 View

Confronto tra pari

Modifica del prezzo

Merck KGaA Previsione

Obiettivo di Prezzo

By TipRanks

31.63% in crescita

Previsioni per 12 mesi

Media 149 EUR  31.63%

Alto 182 EUR

Basso 130 EUR

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Merck KGaA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

7 ratings

5

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

121.15 / 123.55Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Neutral Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

72 / 351 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Merck KGaA

There is no Profile data available for MRK.BE.
help-icon Live chat